Cargando…

Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures

Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggeste...

Descripción completa

Detalles Bibliográficos
Autores principales: Mota, Nina Roth, Poelmans, Geert, Klein, Marieke, Torrico, Bàrbara, Fernàndez-Castillo, Noèlia, Cormand, Bru, Reif, Andreas, Franke, Barbara, Arias Vásquez, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234984/
https://www.ncbi.nlm.nih.gov/pubmed/31896117
http://dx.doi.org/10.1038/s41386-019-0592-4
_version_ 1783535878496321536
author Mota, Nina Roth
Poelmans, Geert
Klein, Marieke
Torrico, Bàrbara
Fernàndez-Castillo, Noèlia
Cormand, Bru
Reif, Andreas
Franke, Barbara
Arias Vásquez, Alejandro
author_facet Mota, Nina Roth
Poelmans, Geert
Klein, Marieke
Torrico, Bàrbara
Fernàndez-Castillo, Noèlia
Cormand, Bru
Reif, Andreas
Franke, Barbara
Arias Vásquez, Alejandro
author_sort Mota, Nina Roth
collection PubMed
description Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N = 53,293, N = 681,275, and N = 98,697, respectively). We then conducted genome-wide ADHD–BMI and ADHD–obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD–BMI overlapping genes with brain volumes (primary GWAS data N = 10,720–10,928; replication data N = 9428). The dopaminergic gene set was associated with both ADHD (P = 5.81 × 10(−3)) and BMI (P = 1.63 × 10(−5)); the circadian rhythm was associated with BMI (P = 1.28 × 10(−3)). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD–BMI and ADHD–obesity results. The ADHD–BMI overlapping genes were associated with putamen volume (P = 7.7 × 10(−3); replication data P = 3.9 × 10(−2))—a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD–obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions.
format Online
Article
Text
id pubmed-7234984
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-72349842020-05-19 Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures Mota, Nina Roth Poelmans, Geert Klein, Marieke Torrico, Bàrbara Fernàndez-Castillo, Noèlia Cormand, Bru Reif, Andreas Franke, Barbara Arias Vásquez, Alejandro Neuropsychopharmacology Article Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N = 53,293, N = 681,275, and N = 98,697, respectively). We then conducted genome-wide ADHD–BMI and ADHD–obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD–BMI overlapping genes with brain volumes (primary GWAS data N = 10,720–10,928; replication data N = 9428). The dopaminergic gene set was associated with both ADHD (P = 5.81 × 10(−3)) and BMI (P = 1.63 × 10(−5)); the circadian rhythm was associated with BMI (P = 1.28 × 10(−3)). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD–BMI and ADHD–obesity results. The ADHD–BMI overlapping genes were associated with putamen volume (P = 7.7 × 10(−3); replication data P = 3.9 × 10(−2))—a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD–obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions. Springer International Publishing 2020-01-02 2020-06 /pmc/articles/PMC7234984/ /pubmed/31896117 http://dx.doi.org/10.1038/s41386-019-0592-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Mota, Nina Roth
Poelmans, Geert
Klein, Marieke
Torrico, Bàrbara
Fernàndez-Castillo, Noèlia
Cormand, Bru
Reif, Andreas
Franke, Barbara
Arias Vásquez, Alejandro
Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
title Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
title_full Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
title_fullStr Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
title_full_unstemmed Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
title_short Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
title_sort cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between attention-deficit/hyperactivity disorder and obesity measures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234984/
https://www.ncbi.nlm.nih.gov/pubmed/31896117
http://dx.doi.org/10.1038/s41386-019-0592-4
work_keys_str_mv AT motaninaroth crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT poelmansgeert crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT kleinmarieke crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT torricobarbara crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT fernandezcastillonoelia crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT cormandbru crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT reifandreas crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT frankebarbara crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures
AT ariasvasquezalejandro crossdisordergeneticanalysesimplicatedopaminergicsignalingasabiologicallinkbetweenattentiondeficithyperactivitydisorderandobesitymeasures